Envista Holdings Corporation (NVST)
NYSE: NVST · Dental Equipment & Supplies · Brea, CA
Our rating: Cautious
Cautious reaffirmed at $24.03, moderate conviction, November 16, 2026.
Breaks if: The Cautious call is wrong if Envista's next two quarterly filings — covering the six months through mid-2027 — together show cumulative free cash flow above $110M and year-over-year revenue growth at or above 7% in each period, confirming that the November patent invalidations have not impaired cash generation or top-line momentum. If both conditions hold simultaneously, the IP damage looks contained and the basis for Cautious dissolves.
Key figures
| Market value | $3.7B |
|---|---|
| Revenue, last 12 months | $2.9B |
| Net income, last 12 months | $634M |
| Free cash flow, last 12 months | $242M |
| Price to earnings | 5.8× |
| Free cash flow yield | 6.6% |
| Dividend yield | 0.0% |
| Operating margin | 25.4% |
| Return on equity | 20.5% |
| Beta to the S&P 500 | 1.18 |
| Volatility, annualized | 40.2% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| October 2, 2026 | $692M | 3.2% | $3.11 | $62M |
| July 3, 2026 | $731M | 7.1% | $0.33 | $104M |
| April 3, 2026 | $706M | 14.4% | $0.23 | −$16M |
| December 31, 2025 | $751M | 15.0% | $0.20 | $92M |
| September 26, 2025 | $670M | 11.5% | $-0.18 | $68M |
| June 27, 2025 | $682M | 7.7% | $0.16 | $76M |
| March 28, 2025 | $617M | −1.1% | $0.10 | −$6M |
| December 31, 2024 | $653M | 1.1% | $0.01 | $124M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.82B: Claude 35%, Gemini 25%, Mistral 15%
- Diluted earnings per share are at least $0.20: Claude 55%, Gemini 80%, Mistral 70%
- Free cash flow for the quarter is at least $0.09B: Claude 50%, Gemini 55%, Mistral 40%
- Backlog at the end of the quarter is at least $0.17B: Claude 55%, Gemini 70%, Mistral 85%
13 ledger entries and 31 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.